Cabuga, Teselyn G.

HRN: 17-33-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2022
CEFUROXIME 1.5GM (VIAL)
09/06/2022
09/13/2022
IV
1.5grams
Q8
Acute Pyelonephritis

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Non-compliant To Guidelines